Trial Profile
A study to evaluate safety and efficacy of Etanercept bio-similars with reference Etanercept & with each other in children with juvenile idiopathic arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jan 2017
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 25 Jan 2017 New trial record